EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Modified Cardiometabolic Index and Incident Surrogate-Defined Cardiovascular–Liver–Metabolic Multimorbidity Among Middle-Aged and Older Adults in China: A Prospective Cohort Study from the China Health and Retirement Longitudinal Study (CHARLS)

Modifizierter kardiometabolischer Index und neu auftretende surrogatdefinierte kardiovaskulär-leber-metabolische Multimorbidität bei mittelalten und älteren Erwachsenen in China: prospektive Kohortenstudie aus der China Health and Retirement Longitudinal Study (CHARLS)

Feng Liang, Yijie Huang, Haiping Chen, Zhaohua Cai, Yi Li, Ben He

Medical Sciences · 09.11.2026 · 14 (7) · 764

DOI: 10.3390/medsci14070764 ↗

Auf einen Blick

Bei 6.124 CHARLS-Teilnehmenden war ein höherer MCMI mit neu auftretender surrogatdefinierter CLMM assoziiert. Die Stärke des Zusammenhangs hing jedoch von der Behandlung unklarer Verläufe ab.

Fragestellung

Ist der modified cardiometabolic index (MCMI) mit incidenter surrogatdefinierter CLMM bei Erwachsenen ab 45 Jahren in China assoziiert?

Methode

Prospektive Kohortenstudie in CHARLS; 6.124 Teilnehmende ab 45 Jahren; multivariable logistische Regression, restricted cubic splines und ROC-Analysen; Follow-up über etwa 4 Jahre.

Ergebnisse

619 Teilnehmende (10,11 %) erfüllten über etwa 4 Jahre die surrogatdefinierte CLMM-Definition. Fully adjusted OR für MCMI Q4 vs. Q1: 6,13 (95 %-KI 4,34–8,66); AUC 0,684 (0,664–0,705).

Einschränkungen

1919 Fälle mit unbestimmtem Follow-up wurden primär als Nicht-CLMM gewertet; unabhängige Validierung fehlte.

Schlussfolgerung der Autor:innen

MCMI war mit incidenter surrogatdefinierter CLMM assoziiert, doch ein großer Teil des Zusammenhangs schien auf vorhandene Komponentenlast und die MASLD-Komponente zurückzugehen.

Kernaussagen

  • 619 von 6.124 Teilnehmenden entwickelten CLMM
  • MCMI Q4 vs. Q1: OR 6,13 (95 %-KI 4,34–8,66)
  • AUC 0,684; nicht besser als BMI oder Waist-to-Height Ratio

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Kohortenstudie in der Zeitschrift Medical Sciences, online erschienen am 09.11.2026. Verfasst von Feng Liang und 5 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Postdoctoral Scientific Research Foundation of Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine.

Auf einen BlickAbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Defined by the coexistence of at least two cardiovascular diseases, type 2 diabetes and suspected metabolic dysfunction-associated steatotic liver disease, cardiovascular–liver–metabolic multimorbidity (CLMM) is an emerging phenotype that is related to the cardiovascular–kidney–metabolic continuum yet distinct from it. By combining triglycerides, fasting glucose, HDL cholesterol and central adiposity, the modified cardiometabolic index (MCMI) summarizes these features in a single fasting-panel measure. Evidence to date has been confined to cross-sectional fatty-liver and self-reported outcomes; established lipid–glucose indices have not been compared head to head with MCMI for CLMM.

Methods

We included 6124 CHARLS participants aged 45 years or older, free of CLMM in 2011 and with a 2015 health questionnaire. For the primary analysis, we assigned indeterminate follow-up outcomes (n = 1919) to non-CLMM; results from determinable-outcome and multiple-imputation analyses are presented beside the primary estimates, along with additional alternative assumptions. We used multivariable logistic regression, restricted cubic splines and paired ROC analyses. Exploratory analyses compared MCMI with 12 other indices. We also examined joint MCMI–CRP associations and interaction, subgroup, sensitivity and component-specific analyses, together with incremental models and bootstrap internal validation.

Results

Over approximately four years, 619 participants (10.11%) fulfilled the surrogate-defined CLMM definition, with suspected MASLD documented in 93.4% of cases. A nonlinear association was observed (p < 0.001). The fully adjusted MCMI Q4-versus-Q1 odds ratio was 6.13 (95% CI 4.34–8.66) in the primary analysis, 6.67 (4.70–9.49) among participants with determinable outcomes and 5.69 (4.24–7.65) after multiple imputation of missing components, but 1.74 (1.49–2.02) if all indeterminate outcomes were assumed to be cases. Adjusting for baseline component count reduced the odds ratio from 6.38 to 3.22 (2.17–4.78) across the same 6064 participants. Per-SD odds ratios were 3.63 (3.01–4.37) for incident suspected MASLD versus 1.10 (1.00–1.21) for incident CVD. MCMI had an apparent AUC of 0.684 (0.664–0.705); differences from BMI and waist-to-height ratio were not statistically significant. After bootstrap optimism correction, the covariate model had AUCs of 0.697 with MCMI and 0.698 with BMI, and adding MCMI to separately modelled glucose, triglycerides, HDL cholesterol and waist circumference did not significantly improve model fit (p = 0.263). The high-MCMI/high-CRP group had an odds ratio of 3.29 (2.55–4.25) versus the double-low group, but interaction tests were not significant.

Conclusions

MCMI was associated with incident surrogate-defined CLMM, yet much of the observed association appeared attributable to pre-existing component burden and to the LAP-based suspected MASLD component sharing inputs with MCMI, while its magnitude varied with the treatment of indeterminate outcomes. Its exploratory apparent discrimination was not significantly different from that of BMI or waist-to-height ratio. Interpretation remains limited by the lack of independent validation; the joint MCMI–CRP findings did not establish interaction or biological synergy.

Förderung

  • Postdoctoral Scientific Research Foundation of Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine

Zitieren

APA

Liang, F., Huang, Y., Chen, H., Cai, Z., Li, Y., & He, B. (2026). Modified Cardiometabolic Index and Incident Surrogate-Defined Cardiovascular–Liver–Metabolic Multimorbidity Among Middle-Aged and Older Adults in China: A Prospective Cohort Study from the China Health and Retirement Longitudinal Study (CHARLS). Medical Sciences, 14(7), 764. https://doi.org/10.3390/medsci14070764

Vancouver

Liang F, Huang Y, Chen H, Cai Z, Li Y, He B. Modified Cardiometabolic Index and Incident Surrogate-Defined Cardiovascular–Liver–Metabolic Multimorbidity Among Middle-Aged and Older Adults in China: A Prospective Cohort Study from the China Health and Retirement Longitudinal Study (CHARLS). Medical Sciences. 2026;14(7):764. doi:10.3390/medsci14070764

BibTeX
@article{Liang2026,
  author = {Liang, Feng and Huang, Yijie and Chen, Haiping and Cai, Zhaohua and Li, Yi and He, Ben},
  title = {Modified Cardiometabolic Index and Incident Surrogate-Defined Cardiovascular–Liver–Metabolic Multimorbidity Among Middle-Aged and Older Adults in China: A Prospective Cohort Study from the China Health and Retirement Longitudinal Study (CHARLS)},
  journal = {Medical Sciences},
  year = {2026},
  volume = {14},
  number = {7},
  pages = {764},
  doi = {10.3390/medsci14070764}
}
Kostenlos starten →